Reply to Oegema et al.: CFI-400945 and Polo-like kinase 4 inhibition

Affiliations

• ¹ Department of Thoracic/Head and Neck Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
• ² Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
• ³ Department of Melanoma Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
• ⁴ Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
• ⁵ The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada.
• ⁶ Department of Medicine, University of Toronto, Toronto, ON M5G 1L7, Canada.
• ⁷ The Campbell Family Institute for Breast Cancer Research at Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 2M9, Canada; tak.mak@uhnresearch.ca.
• ⁸ Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
• ⁹ Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
• ¹⁰ Leidos Biomedical Research, Frederick National Laboratory for Cancer Research, Frederick, MD 21701.